Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
News Focus
Star Diamond: High Modelled Diamond Prices and High Proportions of Type IIa Diamonds (click to learn more)
Northstar Discovers Large Near Surface EM Conductor SE of Cam Copper Mine (click to learn more)
Xcyte Digital Corp. Releases "Xperience" Subscription Service (click to learn more)
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Antibe Therapeutics Inc(Pre-Merger)
T.ATE
Alternate Symbol(s):
ATBPF
Healthcare
Antibe Therapeutics Inc. is a clinical-stage biotechnology company. The Company is leveraging its hydrogen sulfide (H2S) platform to develop therapies to target inflammation arising from a range of medical conditions. The Company’s pipeline includes assets that seek to overcome the gastrointestinal ulcers and bleeding associated with nonsteroidal anti-inflammatory drugs (NSAIDs). Its lead drug,...
otenaproxesul, is in clinical development as an alternative to opioids and NSAIDs for acute pain. Its second pipeline drug, ATB-352, is being developed for a specialized pain indication. The Company also focuses on inflammatory bowel disease (IBD). Otenaproxesul combines a moiety that releases hydrogen sulfide with naproxen, a non-steroidal, anti-inflammatory drug. ATB-352 is an H2S-releasing derivative of ketoprofen, a potent NSAID commonly prescribed for acute pain. Its IBD candidates are being designed to maintain the efficacy, safety, and pharmacokinetic properties of ATB-429.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (TSX:ATE)
New Post
View:
Posts & Comments
Threaded Posts
Prev
...
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
...
Next
(26)
•••
Pronorvista
X
View Profile
View Bullboard History
Post by
Pronorvista
on Nov 01, 2023 9:12pm
ATE
Market By Price Price Total Volume Value 0.940 500 $470 0.890 11,000 $9,790 0.880 4,400
...more
(31)
•••
Quailman
X
View Profile
View Bullboard History
Comment by
Quailman
on Nov 01, 2023 2:13pm
RE:Lots of selling
This stock was pretty solid a few years ago at $4 and a high just under $8. I bought more over news today. I agree on taking profit most times but not here. Don't sell yourself short. GLTA
GameSquare Announces Formation of FaZe Media, a Creator-led IP and Media Company, led by CEO FaZe Banks and Backed by $11 Million Investment from Matt Kalish
posted May 16, 2024 9:00am by
GameSquare Holdings Inc.
-
|
Justin Kenna, CEO of GameSquare stated, "Since completing the acquisition of FaZe Clan, we have focused on returning FaZe's founders to reboot their brand and reestablish its authenticity. We are thrilled to better capitalize this business for growth with $11 million in new capital from Matt, and to strengthen the FaZe Media board with his addition. Matt deeply believes in the power of founder and creator-led organizations and ...read more
(842)
•••
Duster340
X
View Profile
View Bullboard History
Post by
Duster340
on Nov 01, 2023 12:39pm
Lots of selling
into this rally. including myself taking some profit. i think the pk/pd is a low bar. P2 is the real hurdle to clear if we can do that then it will be a huge move higher.
(842)
•••
Duster340
X
View Profile
View Bullboard History
Post by
Duster340
on Nov 01, 2023 12:27pm
That is only
1/2 of the results. to go higher we need another possitive result next week. We look forward to analyzing and reporting on the PK results next week.”
(55)
•••
Harper75
X
View Profile
View Bullboard History
Comment by
Harper75
on Nov 01, 2023 11:17am
RE:ATE
Exciting times. I don't have any SP predictions but after a successful Phase 2 Antibe will have mitigated a major risk/obstacle that halted previous progress. How that will translate
...more
(26)
•••
Pronorvista
X
View Profile
View Bullboard History
Post by
Pronorvista
on Nov 01, 2023 11:01am
ATE
Very good news, probably closed between 0.80 and 0.90 by Friday.
(1931)
•••
Betteryear2
X
View Profile
View Bullboard History
Post by
Betteryear2
on Nov 01, 2023 10:33am
Antibe Completes First Clinical Study
November 01, 2023 07:00 AM Eastern Daylight Time TORONTO--(BUSINESS WIRE)--Antibe Therapeutics Inc. (TSX: ATE, OTCQX: ATBPF), a clinical-stage biotechnology company leveraging its hydrogen
...more
(0)
•••
PressRelease
X
View Profile
View Bullboard History
Post by
PressRelease
on Nov 01, 2023 7:03am
New Press Release - Antibe Completes First Clinical Study of Otenaproxesul's New Formulation
- All treatments well tolerated with no adverse safety signals- No elevations in liver enzymes Antibe Therapeutics Inc. (TSX: ATE, OTCQX: ATBPF), a clinical-stage biotechnology company leveraging its hydrogen sulfide platform to develop next-generation therapies targeting pain and inflammation,...
read article.
(26)
•••
Pronorvista
X
View Profile
View Bullboard History
Post by
Pronorvista
on Oct 31, 2023 3:45pm
ATE
Market By Price Price Total Volume Value 0.830 6,200 $5,146 0.800 2,000 $1,600 0.790 10
...more
(842)
•••
Duster340
X
View Profile
View Bullboard History
Comment by
Duster340
on Oct 30, 2023 8:23pm
RE:RE:RE:As end-of-month approaches ...
still waiting for the decision that is what will be kicked down the road? Completed in-person arbitration proceeding with Nuance Pharma; decision now expected in the upcoming quarter
(37)
•••
TheMadMonk
X
View Profile
View Bullboard History
Comment by
TheMadMonk
on Oct 30, 2023 6:21pm
RE:RE:As end-of-month approaches ...
Dusty, what litigation is going to be kicked down the road? The arbitration proceedings have already wrapped up (August 14th or 15th) and we are simply waiting for the
...more
(55)
•••
Harper75
X
View Profile
View Bullboard History
Comment by
Harper75
on Oct 30, 2023 12:34pm
RE:Read between the lines
What "between the lines" narrative are you picking up from this quote?
(842)
•••
Duster340
X
View Profile
View Bullboard History
Post by
Duster340
on Oct 30, 2023 11:20am
Read between the lines
“With tablets in hand, we’re excited to be approaching several near-term catalysts,” commented Dan Legault, Antibe’s CEO. “We’ll kick off our otenaproxesul clinical program in the fall with a short PK
...more
(842)
•••
Duster340
X
View Profile
View Bullboard History
Comment by
Duster340
on Oct 30, 2023 11:04am
RE:As end-of-month approaches ...
i think we will find out soon that litigation gets kicked down the road as there will be a deal to be made with nuance if ATE is succesful with P2
Prev
...
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
...
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
Drilling Approval Received for New Mexico Lithium Project
This Gambling Tech Stock is Future-Proofing the World’s Casinos and has No Direct Competition
GameSquare Announces Formation of FaZe Media, Backed by $11M Investment
IAMGOLD Reports First Quarter 2024 Results
Xcyte Digital Corp. Releases "Xperience" Subscription Service